FDA Global Pharma Safety Plan Looks To Food Model
This article was originally published in The Tan Sheet
Executive Summary
FDA seeks new authority over the international drug supply chain to support a global safety plan.
You may also be interested in...
FDA Envisions International Focus Groups Navigating Globalization Issues
FDA could help create several international coalitions to carry out the agency’s globalization plan, which could allow for issue-specific groups focused on individual pharmaceutical sectors.
Collaboration On Foreign Inspections Helps FDA Improve Resource Allocations
FDA better allocated resources for foreign inspections based on information European and Australian authorities shared in a two-year pilot program, including conducting good manufacturing practices inspections that met the needs of multiple agencies.
Private Third-Party Audits Could Enhance FDA’s Manufacturing Risk Analysis
Private and third-party audits could direct FDA to problematic facilities while easing some inspection burden on firms that already comply, but not replace FDA’s typical inspection duties.